Research Interests
- Vaccine Development
- Infectious Diseases
- Cancer Immunotherapy
- Mucosal Immunology
Education
Medical School: National University of Saint Augustine School of Medicine (PERU)
Graduate Training: University of Pittsburgh School of Medicine, Tumor Immunology
Post-doctoral Training: University of Pittsburgh School of Medicine, Mucosal Immunology
Contact Information
Email: Vicettimiguel.1@osu.eduPhone: 614-366-0679
Research Projects
Our research team is developing cellular and synthetic vaccines that induce T cell responses, which provide prophylaxis against intracellular pathogens and have therapeutic activity against malignancies.
Sex steroids and host defense
Effects of exogenous and endogenous sex steroids on epithelial barrier function and other mechanisms of mucosal immunity.
Effects of exogenous and endogenous sex steroids on epithelial barrier function and other mechanisms of mucosal immunity.
Research Accomplishments
Title: Estrogen Reverses Progestin-Mediated Loss of Genital Mucosal Barrier Function
Dates: 09/01/2018 – 05/31/2023
Name of Agency: NICHD
Role: Co-Investigator
Award Number: R01 HD094634
Dates: 09/01/2018 – 05/31/2023
Name of Agency: NICHD
Role: Co-Investigator
Award Number: R01 HD094634
1. Vicetti Miguel RD*, Quispe Calla NE, Dixon D, Foster RA, Gambotto A, Pavelko SD, Cherpes TL. IL-4-secreting eosinophils promote endometrial stromal cell proliferation and prevent Chlamydia-induced upper genital tract damage. Proc Natl Acad Sci USA 2017, 114(33): E6892-E6901.
2. Vicetti Miguel RD*, Quispe Calla NE, Cherpes TL. Setting sights on Chlamydia immunity's central paradigm: can we hit a moving target? Infect Immun 2017, 85(7): e00129-17.
3. Quispe Calla NE, Vicetti Miguel RD*, Prosper N Boyaka, Luanne Hall-Stoodley, Balveen Kaur, Wayne Trout, Pavelko SD, Cherpes TL. Medroxyprogesterone acetate and levonorgestrel increase
genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Mucosal Immunol 2016, 9(6): 1571-83.
4. Vicetti Miguel RD*, Quispe Calla NE, Pavelko SD, Cherpes TL. Intravaginal Chlamydia trachomatis challenge infection elicits Th1 and Th17 immune responses in mice that promote pathogen clearance and genital tract damage. PLoS ONE 2016, 11(9): e0162445.
5. Vicetti Miguel RD, Harvey S, LaFramboise WA, Reighard SD, Matthews DB & Cherpes TL. Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity. PLoS ONE 2013, 8(3): e58565.
6. Vicetti Miguel RD, Hendricks RL, Aguirre AJ, Melan MA, Terry-Allison T, Thomson AW & Cherpes TL. Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection. J Immunol 2012, 189(7): 3449-61.
7. Vicetti Miguel RD, Cherpes TL, Watson LJ, McKenna KC. CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination. J Immunol 2010, 185(11): 6706-18.
* Corresponding author
Complete list of publications: https://www.ncbi.nlm.nih.gov/myncbi/1dSL8iSmv1Zkb/bibliography/public/
2. Vicetti Miguel RD*, Quispe Calla NE, Cherpes TL. Setting sights on Chlamydia immunity's central paradigm: can we hit a moving target? Infect Immun 2017, 85(7): e00129-17.
3. Quispe Calla NE, Vicetti Miguel RD*, Prosper N Boyaka, Luanne Hall-Stoodley, Balveen Kaur, Wayne Trout, Pavelko SD, Cherpes TL. Medroxyprogesterone acetate and levonorgestrel increase
genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Mucosal Immunol 2016, 9(6): 1571-83.
4. Vicetti Miguel RD*, Quispe Calla NE, Pavelko SD, Cherpes TL. Intravaginal Chlamydia trachomatis challenge infection elicits Th1 and Th17 immune responses in mice that promote pathogen clearance and genital tract damage. PLoS ONE 2016, 11(9): e0162445.
5. Vicetti Miguel RD, Harvey S, LaFramboise WA, Reighard SD, Matthews DB & Cherpes TL. Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity. PLoS ONE 2013, 8(3): e58565.
6. Vicetti Miguel RD, Hendricks RL, Aguirre AJ, Melan MA, Terry-Allison T, Thomson AW & Cherpes TL. Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection. J Immunol 2012, 189(7): 3449-61.
7. Vicetti Miguel RD, Cherpes TL, Watson LJ, McKenna KC. CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination. J Immunol 2010, 185(11): 6706-18.
* Corresponding author
Complete list of publications: https://www.ncbi.nlm.nih.gov/myncbi/1dSL8iSmv1Zkb/bibliography/public/
Additional Information
Research Assistant Professor, 2021 – Current
Department of Otolaryngology - Head and Neck Surgery
Ohio State University College of Medicine
Department of Otolaryngology - Head and Neck Surgery
Ohio State University College of Medicine
2019, Mentorship Program, Society for Mucosal Immunology
2018, Carl Storm Underrepresented Minority Fellowship, Gordon Research Conferences
2018, Travel award, Mucosal Immunology Course & Symposium 2018
2009, Cora Verhagen Prize for the Best Ocular Immunology Presentation, Association for Research in Vision and Ophthalmology
2018, Carl Storm Underrepresented Minority Fellowship, Gordon Research Conferences
2018, Travel award, Mucosal Immunology Course & Symposium 2018
2009, Cora Verhagen Prize for the Best Ocular Immunology Presentation, Association for Research in Vision and Ophthalmology